Literature DB >> 26697885

Amyloid-β Peptide Aβ3pE-42 Induces Lipid Peroxidation, Membrane Permeabilization, and Calcium Influx in Neurons.

Adam P Gunn1, Bruce X Wong1, Timothy Johanssen2, James C Griffith3, Colin L Masters1, Ashley I Bush4, Kevin J Barnham5, James A Duce6, Robert A Cherny7.   

Abstract

Pyroglutamate-modified amyloid-β (pE-Aβ) is a highly neurotoxic amyloid-β (Aβ) isoform and is enriched in the brains of individuals with Alzheimer disease compared with healthy aged controls. Pyroglutamate formation increases the rate of Aβ oligomerization and alters the interactions of Aβ with Cu(2+) and lipids; however, a link between these properties and the toxicity of pE-Aβ peptides has not been established. We report here that Aβ3pE-42 has an enhanced capacity to cause lipid peroxidation in primary cortical mouse neurons compared with the full-length isoform (Aβ(1-42)). In contrast, Aβ(1-42) caused a significant elevation in cytosolic reactive oxygen species, whereas Aβ3pE-42 did not. We also report that Aβ3pE-42 preferentially associates with neuronal membranes and triggers Ca(2+) influx that can be partially blocked by the N-methyl-d-aspartate receptor antagonist MK-801. Aβ3pE-42 further caused a loss of plasma membrane integrity and remained bound to neurons at significantly higher levels than Aβ(1-42) over extended incubations. Pyroglutamate formation was additionally found to increase the relative efficiency of Aβ-dityrosine oligomer formation mediated by copper-redox cycling.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Alzheimer disease; amyloid-beta (Aβ); dityrosine; lipid peroxidation; oligomer; pyroglutamate; reactive oxygen species (ROS)

Mesh:

Substances:

Year:  2015        PMID: 26697885      PMCID: PMC4813569          DOI: 10.1074/jbc.M115.655183

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  70 in total

1.  Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader.

Authors:  H Wang; J A Joseph
Journal:  Free Radic Biol Med       Date:  1999-09       Impact factor: 7.376

2.  The A beta 3-pyroglutamyl and 11-pyroglutamyl peptides found in senile plaque have greater beta-sheet forming and aggregation propensities in vitro than full-length A beta.

Authors:  W He; C J Barrow
Journal:  Biochemistry       Date:  1999-08-17       Impact factor: 3.162

3.  Tyrosine gated electron transfer is key to the toxic mechanism of Alzheimer's disease beta-amyloid.

Authors:  Kevin J Barnham; Fredrik Haeffner; Giuseppe D Ciccotosto; Cyril C Curtain; Deborah Tew; Christine Mavros; Konrad Beyreuther; Darryl Carrington; Colin L Masters; Robert A Cherny; Roberto Cappai; Ashley I Bush
Journal:  FASEB J       Date:  2004-07-01       Impact factor: 5.191

4.  Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers.

Authors:  Angelo Demuro; Erene Mina; Rakez Kayed; Saskia C Milton; Ian Parker; Charles G Glabe
Journal:  J Biol Chem       Date:  2005-02-17       Impact factor: 5.157

5.  Toxicity of pyroglutaminated amyloid beta-peptides 3(pE)-40 and -42 is similar to that of A beta1-40 and -42.

Authors:  T L Tekirian; A Y Yang; C Glabe; J W Geddes
Journal:  J Neurochem       Date:  1999-10       Impact factor: 5.372

6.  Hydrogen peroxide is generated during the very early stages of aggregation of the amyloid peptides implicated in Alzheimer disease and familial British dementia.

Authors:  Brian J Tabner; Omar M A El-Agnaf; Stuart Turnbull; Matthew J German; Katerina E Paleologou; Yoshihito Hayashi; Leanne J Cooper; Nigel J Fullwood; David Allsop
Journal:  J Biol Chem       Date:  2005-09-01       Impact factor: 5.157

7.  beta-amyloid is different in normal aging and in Alzheimer disease.

Authors:  Alessandra Piccini; Claudio Russo; Alessandra Gliozzi; Annalisa Relini; Antonella Vitali; Roberta Borghi; Luca Giliberto; Andrea Armirotti; Cristina D'Arrigo; Angela Bachi; Angela Cattaneo; Claudio Canale; Silvia Torrassa; Takaomi C Saido; William Markesbery; Pierluigi Gambetti; Massimo Tabaton
Journal:  J Biol Chem       Date:  2005-08-15       Impact factor: 5.157

8.  Products of Cu(II)-catalyzed oxidation in the presence of hydrogen peroxide of the 1-10, 1-16 fragments of human and mouse beta-amyloid peptide.

Authors:  Teresa Kowalik-Jankowska; Monika Ruta; Kornelia Wiśniewska; Leszek Łankiewicz; Marcin Dyba
Journal:  J Inorg Biochem       Date:  2004-06       Impact factor: 4.155

9.  Copper mediates dityrosine cross-linking of Alzheimer's amyloid-beta.

Authors:  Craig S Atwood; George Perry; Hong Zeng; Yoji Kato; Walton D Jones; Ke-Qing Ling; Xudong Huang; Robert D Moir; Dandan Wang; Lawrence M Sayre; Mark A Smith; Shu G Chen; Ashley I Bush
Journal:  Biochemistry       Date:  2004-01-20       Impact factor: 3.162

10.  Glutaminyl cyclases unfold glutamyl cyclase activity under mild acid conditions.

Authors:  Stephan Schilling; Torsten Hoffmann; Susanne Manhart; Matthias Hoffmann; Hans-Ulrich Demuth
Journal:  FEBS Lett       Date:  2004-04-09       Impact factor: 4.124

View more
  27 in total

Review 1.  Spreading of Pathology in Alzheimer's Disease.

Authors:  Zhong-Yue Lv; Chen-Chen Tan; Jin-Tai Yu; Lan Tan
Journal:  Neurotox Res       Date:  2017-06-16       Impact factor: 3.911

2.  N2L, a novel lipoic acid-niacin dimer protects HT22 cells against β-amyloid peptide-induced damage through attenuating apoptosis.

Authors:  Rikang Wang; Lang Zhang; Rifang Liao; Qian Li; Rongbiao Pi; Xiaobo Yang
Journal:  Metab Brain Dis       Date:  2019-09-02       Impact factor: 3.584

3.  A modification-specific peptide-based immunization approach using CRM197 carrier protein: Development of a selective vaccine against pyroglutamate Aβ peptides.

Authors:  Valérie Vingtdeux; Haitian Zhao; Pallavi Chandakkar; Christopher M Acker; Peter Davies; Philippe Marambaud
Journal:  Mol Med       Date:  2016-11-28       Impact factor: 6.354

4.  Granisetron Alleviates Alzheimer's Disease Pathology in TgSwDI Mice Through Calmodulin-Dependent Protein Kinase II/cAMP-Response Element Binding Protein Pathway.

Authors:  Sweilem B Al Rihani; Renny S Lan; Amal Kaddoumi
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

Review 5.  β-Amyloid Peptide: the Cell Compartment Multi-faceted Interaction in Alzheimer's Disease.

Authors:  Pasquale Picone; Domenico Nuzzo; Daniela Giacomazza; Marta Di Carlo
Journal:  Neurotox Res       Date:  2019-12-06       Impact factor: 3.911

Review 6.  Targeting the alternative oxidase (AOX) for human health and food security, a pharmaceutical and agrochemical target or a rescue mechanism?

Authors:  Marten Szibor; Christina Schenkl; Mario R O Barsottini; Luke Young; Anthony L Moore
Journal:  Biochem J       Date:  2022-06-30       Impact factor: 3.766

Review 7.  Are N- and C-terminally truncated Aβ species key pathological triggers in Alzheimer's disease?

Authors:  Julie Dunys; Audrey Valverde; Frédéric Checler
Journal:  J Biol Chem       Date:  2018-08-24       Impact factor: 5.157

8.  Alzheimer's disease improved through the activity of mitochondrial chain complexes and their gene expression in rats by boswellic acid.

Authors:  Tarek M Mohamed; Menna Allah M Youssef; Azza A Bakry; Mai M El-Keiy
Journal:  Metab Brain Dis       Date:  2020-11-07       Impact factor: 3.584

9.  β-Ecdysterone protects SH-SY5Y cells against β-amyloid-induced apoptosis via c-Jun N-terminal kinase- and Akt-associated complementary pathways.

Authors:  Xiaojie Zhang; Miaoxian Dong; Tianjiao Xu; Chengu Niu
Journal:  Lab Invest       Date:  2018-01-12       Impact factor: 5.662

10.  Lipid-Chaperone Hypothesis: A Common Molecular Mechanism of Membrane Disruption by Intrinsically Disordered Proteins.

Authors:  Michele F Sciacca; Fabio Lolicato; Carmelo Tempra; Federica Scollo; Bikash R Sahoo; Matthew D Watson; Sara García-Viñuales; Danilo Milardi; Antonio Raudino; Jennifer C Lee; Ayyalusamy Ramamoorthy; Carmelo La Rosa
Journal:  ACS Chem Neurosci       Date:  2020-12-03       Impact factor: 4.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.